Evidence map›Paper›PMID 33344569›Full record

ArticleWorld journal of clinical cases2020

Gastric mixed adenoma-neuroendocrine tumor: A case report.

Shuzo Kohno, Hiroaki Aoki, Masayuki Kato, Masaich Ogawa, Kazuhiko Yoshida

Open access · diamondAbstract readCase Reports
In one paragraph

Article in World journal of clinical cases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. A Case of Gastric Mixed Neuroendocrine-Nonneuroendocrine Neoplasm Composed With Adenoma and Neuroendocrine Tumor.The Korean journal of helicobacter and upper gastrointestinal research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shuzo KohnoDepartment of Surgery, The Jikei University Katsushika Medical Center, Tokyo 125-8506, Katsushika-ku, Japan. s-kohno@jikei.ac.jp.
Hiroaki AokiDepartment of Surgery, The Jikei University Katsushika Medical Center, Tokyo 125-8506, Katsushika-ku, Japan.
Masayuki KatoDepartment of Endoscopy, The Jikei University Katsushika Medical Center, Tokyo 125-8506, Katsushika-ku, Japan.
Masaich OgawaDepartment of Surgery, The Jikei University Katsushika Medical Center, Tokyo 125-8506, Katsushika-ku, Japan.
Kazuhiko YoshidaDepartment of Surgery, The Jikei University Katsushika Medical Center, Tokyo 125-8506, Katsushika-ku, Japan.
Katsushika Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGastric mixed adenoma-neuroendocrine tumors (NETs) are quite rare. In the 2019 world health organization classification of tumors of the digestive system, these were designated as a combination of grade 1 or grade 2 NETs and adenomas or tubular adenomas. There are no treatment guidelines for these tumors, and pathological and clinical studies are ongoing. Herein, we review previous case reports and present a case of gastric mixed adenoma-NET. CASE SUMMARY: A 66-year-old man underwent gastrointestinal endoscopy for the evaluation of upper abdominal pain. Histopathological examination of the biopsy specimen indicated the possibility of gastric cancer. A histopathological examination by endoscopic submucosal dissection showed a mixed adenoma-NET that was completely excised by endoscopic submucosal dissection. No recurrence was observed on gastrointestinal endoscopy at the 6-mo follow-up.

conclusionClinicians' awareness of this rare tumor is important for its timely diagnosis and treatment.

Indexed as

AdenomaCase reportDiagnosisNeuroendocrine tumorPathologyStomach treatment

Identifiers

PMID33344569
PMCPMC7716298
OpenAlexW3108827406

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.